ArticleIndian journal of plastic surgery : official publication of the Association of Plastic Surgeons of India2026
Study of Nonculture Epidermal Suspension in the Treatment of Stable Vitiligo.
Article in Indian journal of plastic surgery : official publication of the Association of Plastic Surgeons of India, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Vitiligo is a chronic autoimmune disorder characterized by skin depigmentation. Nonculture epidermal suspension has emerged as a promising treatment for stable vitiligo. Objective: This article evaluates the efficacy and safety of nonculture epidermal suspension in patients with stable vitiligo. Materials and Methods: Fifty-one patients with stable vitiligo underwent nonculture epidermal suspension treatment between 2016 and 2022. Repigmentation was assessed at 1 month, 3 months, 6 months, and 1 year. Factors affecting outcomes were analyzed. Results: The mean repigmentation was 68% (95% confidence interval: 62.7-73.9%) with 43.1% of patients achieving excellent repigmentation. Long-term follow-up (> 2 years) in 32 patients showed 78% maintained stable repigmentation. Minor adverse events occurred in 13.7% of patients with no serious complications reported. Conclusion: Nonculture epidermal suspension is an effective, simple, and safe procedure for stable vitiligo with sustained long-term results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.